Affiliations 

  • 1 a International Medical University , Kuala Lumpur , Malaysia and
  • 2 b Centre for Pharmaceutical Innovation and Development (CPID), School of Pharmacy and Medical Sciences, University of South Australia , Adelaide , SA , Australia
Drug Dev Ind Pharm, 2015;41(11):1847-55.
PMID: 25721984 DOI: 10.3109/03639045.2015.1014818

Abstract

Poor biopharmaceutical properties and toxicities associated with the intravenous formulation of docetaxel (DTX) necessitate the exploration of an alternate oral route of delivery.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.